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Abstract  
 
Curcumin is a natural compound that exhibits a wide range of beneficial effects, among them 
the anti-tumor activity. Recently it was shown that curcumin may be efficient against drug 
resistant tumor cells. The goal of our investigation was to examine if human laryngeal 
carcinoma cells resistant to carboplatin display sensitivity to curcumin, as compared to 
parental cells, and if this sensitivity is altered, to determine the molecular mechanisms that are 
responsible for it. We found that carboplatin resistant 7T cells were also cross resistant to 
curcumin. After the treatment with equimolar concentration of curcumin, 7T cells exhibited 
lower intracellular accumulation of curcumin which coincided with reduced formation of 
reactive oxygen species (ROS), diminished lipid and DNA damage followed by reduced 
induction of apoptosis and expression of heat shock protein 70 (Hsp70), as compared to 
parental HEp-2 cells. However, after the treatment with equitoxic concentration of curcumin, 
intracellular accumulation and all the explored downstream effects were similar in both cell 
lines suggesting that resistance of 7T cells to curcumin was based on its reduced intracellular 
accumulation. Since curcumin accumulates mostly in the membranes, we explored the fatty 
acid composition of both cell lines, but we did not find any difference between them.  
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1. Introduction 
 
Curcumin (diferuloylmethane) is a yellow pigment derived from the rhizome of the 
plant Curcuma longa. The powdered rhizome of this plant, called turmeric, has been used in 
traditional Chinese and Hindu medicine for centuries in the treatment of different diseases 
(Chattopadhyay et al., 2004). Although curcumin has shown a wide range of beneficial 
pharmacological effects, its anticancer properties have attracted a great interest. It has been 
shown that curcumin can induce the death of cancer cells and inhibit the formation of tumors 
in animal models of carcinogenesis (Kunnumakkara et al., 2008; Lopez-Lazaro, 2008; Teiten 
et al., 2010). Since curcumin influences multiple components of intracellular signaling 
pathways and molecular targets involved in the development and progression of cancer 
(Lopez-Lazaro, 2008; Teiten et al., 2010), it is a promising drug for the treatment of cancer as 
a multifactorial disease. The ongoing clinical trials should determine the possible beneficial 
effect of curcumin in cancer treatment, when given alone or in combination with conventional 
anticancer drugs (Teiten et al., 2010). 
There are numerous reports about the production of reactive oxygen species (ROS) 
during curcumin-induced apoptosis in different tumor cell lines (Atsumi et al., 2005; Chen et 
al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et al., 2005). These free radicals can cause 
serious damage to lipids, proteins, and DNA (Halliwell and Gutteridge, 1999) and they have 
been suggested as some of the initiators in apoptotic signaling (Carmody and Cotter, 2001; 
Circu and Aw, 2010). Unfortunately, tumor cells can often evade apoptosis through many 
different mechanisms. Overexpression of some antiapoptotic proteins like Bcl-2, Bcl-XL and 
Smac protected cancer cells from curcumin treatment (Karunagaran et al., 2005), while some 
curcumin resistant cell lines showed higher production of Hsp70 (Khar et al., 2001; Rashmi et 
al., 2003; Rashmi et al., 2004).  
Resistance of tumor cells to chemotherapy is the major obstacle that limits the 
effectiveness of cancer treatment. Therefore, novel strategies based on new compounds that 
could be efficient against drug resistant tumor cells would be a promising way to increase the 
effectiveness of cancer treatment. Literature data suggest that curcumin exerts the same 
anticancer effects in several drug resistant cell lines as in their sensitive parental counterparts. 
This was shown for multidrug resistant myeloid leukemia cells (Lu et al., 2012), cisplatin 
resistant ovarian cancer cells (Weir et al., 2007), multiple myeloma cells resistant to 
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dexamethasone, doxorubicin and melphalan (Sung et al., 2009), as well as hormone 
independent, multidrug resistant breast cancer cells (Labbozzetta et al., 2009).  
Drug resistance is a general problem in cancer treatment. Since curcumin has been 
shown to be very efficient as anticancer agent in some chemoresistant cell lines, the 
knowledge about the mechanisms involved in modified sensitivity of drug resistant cells to 
this natural compound could be important in future attempts of using curcumin as antitumor 
agent in clinical applications, especially in treatment of drug resistant cancers. The goal of our 
investigation was to examine if human laryngeal carcinoma cells resistant to carboplatin 
display sensitivity to curcumin, as compared to parental cells, and if this sensitivity is altered, 
to determine the molecular mechanisms that are responsible for it. 
 
 
2. Materials and methods  
 
2.1. Cell culture and treatment with curcumin 
Human laryngeal carcinoma HEp-2 cells were obtained from cell culture bank (Gibco, 
Grand Island, NY). Development of their subline resistant to carboplatin has been published 
previously (Osmak et al., 1995). These cells were propagated for 26 passages without 
reversion in sensitivity to carboplatin and are now called 7T. HEp-2 and 7T cells were grown 
at 37ºC with 5% CO2 as a monolayer culture in Dulbecco's modified Eagle's medium, DMEM 
(Gibco), supplemented with 10% newborn  calf serum (Gibco). The doubling times for HEp-2 
and 7T cells were 22 h and 26 h, respectively. Curcumin (Sigma, St. Louis, MO) was 
prepared in dimethylsulfoxide (DMSO) as 50 mM stock solution and stored at -20ºC for no 
longer than two months. After overnight incubation, cells were treated with curcumin in the 
dark (due to its photosensitivity) and diluted in culture medium (final concentration of DMSO 
being lower than 0.08%). After the treatment both adherent and floating cells were collected 
(adherent by tripsinization) centrifuged, counted and used in most of experiments, except for 
those in which the ROS induction was measured. In these experiments the cells were treated 
with curcumin in suspension.   
 
2.2. Cytotoxicity assay 
The sensitivity of cells to curcumin was determined by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT; Sigma) assay (Mickisch et al., 1990). Briefly, 2.500 
HEp-2 cells and 3.500 7T cells were seeded in 180 µl medium in quadruplicate in 96-well 
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tissue culture plates and following overnight incubation treated with curcumin. After 72 h 
MTT was added and the absorbance of the formazan product was measured on a microplate 
reader (Awareness Technology Inc, Palm City, USA) at 600 nm. To examine the influence of 
ROS induction on survival of curcumin treated cells, they were pretreated for 1 h with 10 mM 
N-acetyl-L-cysteine (NAC; Sigma) and than co-treated with curcumin for additional 72 h. 
Survival of cells treated with both NAC and curcumin was calculated according to survival of 
cells treated only with NAC (with approximately 100% survival for both HEp-2 and 7T cells). 
In addition, cells were pretreated with 22.2 µg/ml L-buthionine-sulfoximine (BSO; Sigma) for 
24 h and co-treated with curcumin for the next 48 h. Survival of cells treated with both BSO 
and curcumin was calculated according to survival of cells treated with BSO only (with the 
survival of more than 92% for both, HEp-2 and 7T cells).  
Because the cytotoxic potency (as well as the intracellular accumulation) of a highly 
lipophilic curcumin  in vitro depends on the composition of the in vitro system, i.e. the 
relation between cell number (volume) and medium volume and the binding protein and lipid 
content of the medium, we have done all our experiments in the medium supplemented with 
10 % of newborn  calf serum. In addition, we have examined the influence of cell number and 
the medium volume on the cytotoxicity of curcumin. As shown in Fig. S1, the alteration in 
cell number and in the medium volume that we used in our experiments, did not influence the 
cytotoxicity of curcumin. In addition, in order to have the same seeding density at the time of 
the treatment, we always kept the same ratio between the cell number and surface of the dish 
that we used.  
 
2.3. Accumulation of curcumin 
HEp-2 (4x10
5
/10 ml medium) and 7T cells (6x10
5
/10 ml medium) were seeded in 10 
cm Petri dishes and after overnight incubation treated with curcumin for different time 
periods, collected, washed twice with cold PBS and held on ice until analysis. Due to the fact 
that curcumin exhibits a green fluorescent signal (Khopde et al., 2000; Wang et al., 2006), 
cells were analyzed using the FL1 channel of a FACSCalibur flow cytometer (Becton 
Dickinson; Franklin Lakes, NJ) equipped with laser emitting at 488 nm wavelength. 
Fluorescence emission (above 530 nm) from 10 000 cells was collected and analyzed with BD 
CellQuest Pro software (BD Biosciences, San Jose, CA). 
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2.4. ROS measurement 
The intracellular accumulation of ROS was determined by flow cytometry using the 
2´,7´-dichlorofluorescein diacetate probe (H2DCFDA;  Molecular Probes Invitrogen, Eugene, 
OR). H2DCFDA behaves as a nonfluorescent molecule until acetate groups are removed by 
intracellular esterases. Following oxidation, it becomes a highly fluorescent dye 2´,7´-
dichlorofluorescein (DCF). HEp-2 (1.2 x 10
6
/12 ml medium) and  7T (1.7 x 10
6
/12 ml 
medium) cells were seeded in 10 cm Petri dishes  and following overnight incubation, they 
were collected, resuspended  (2 × 10
5
 cells/ml) in warm PBS without Ca
+2
 and Mg
+2
 ions and 
loaded with 20 µM H2DCFDA for 30 min at 37ºC. After centrifugation, cells were suspended 
in 1 ml DMEM (supplemented with 10% newborn  calf serum (Gibco) without phenol red 
(Gibco)  and treated with curcumin for 15 minutes at 37ºC. Thereafter they were washed with 
PBS without Ca
+2
 and Mg
+2
 ions and the intracellular florescence of DCF was monitored by 
flow cytometry. Fluorescence emission above 530 nm was analyzed from 10000 cells. In each 
experiment three negative controls were used: a) untreated cells, in order to determine the 
contribution from autofluorescence, b) curcumin treated cells, in order to determine the 
contribution from curcumin fluorescence (similarly to DCF curcumin emits fluorescence 
above 530 nm) and c) cells treated with H2DCFDA, in order to determine the level of 
intracellular ROS present before curcumin treatment. 
 
2.5. Lipid peroxidation assay  
Peroxidation of membrane lipids was determined by measuring the level of stabile and 
the most important final product of lipid peroxidation, malondialdehyde (MDA). MDA level 
was detected by HPLC after reaction with thiobarbituric acid. Briefly, HEp-2  (1.2 x 10
6
/12 
ml  medium) and 7T  (1.7 x 10
6
/12 ml medium) cells were seeded in 10 cm Petri dishes  and 
following overnight incubation treated with curcumin for 1 h, collected and washed twice 
with PBS. Supernatant was removed and cell pellets were placed at -80ºC. Afterwards cell 
pellets were sonicated 3 × 3 sec (Ultrasonic processor, Cole Parmer) on ice in the presence of 
5 mM butylated hydroxytoluene (BHT; Sigma) in PBS (in cell concentration of 2 ×10
6
 
cells/75 µl PBS+BHT) to prevent sample oxidation. Then 60 µl of cell lysate were mixed with 
400 µl of 0.1% H3PO4 and 100 µl of thiobarbituric acid and heated for 30 min at 100ºC. After 
heating, the samples were placed on ice to stop reaction. MDA level was determined on 
HPLC with fluorescent detector (set at λex = 524 nm and λem = 551 nm). Concentration of 
MDA in the sample was quantified by peak-area measurement using the linear regression 
curve obtained for MDA standard solutions prepared from MDA standard (1,1,3,3-
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tetramethoxypropane malonaldehyde bis(dimethyl acetal- acetal) (Sigma). Results were 
expressed as nmol/mg protein. Protein concentration in cell lysates was determined by the 
Bradford method. 
 
2.6. DNA damage assay 
HEp-2 (1.2 x 10
6
/12 ml medium) and 7T (1.7 x 10
6
/12 ml medium) cells  were seeded 
in 10 cm Petri dishes  and following overnight incubation treated with curcumin for 1 h, 
collected, washed with PBS and resuspended in ice-cold culture medium (2 × 10
5
 cells/100 
µl). Five microliters of suspension were mixed with 100 µl of 0.5% Low Melting Point 
agarose (Sigma) and analyzed by the alkaline comet assay (Singh et al., 1988). The formation 
of oxidized purines was determined using the formamidopyrimidine glycoslyase (Fpg) 
FLARE™ assay kit (Trevigen Inc, Gaithersburg, MD) with minor modifications (Gajski et 
al., 2008). Slides were analyzed at 250x magnification using an epifluorescent microscope 
(Zeiss, Göttingen, DE) connected trough a camera to an image-analysis system (Comet Assay 
II; Perceptive Instruments Ltd.,
 
Haverhill, Suffolk,
 
UK). The comet parameters, tail length and 
tail moment, were used to measure the level of DNA damage. A total of 200 randomly 
captured nuclei were examined from each slide (100 nuclei from each duplicate slide) in two 
independent experiments. 
 
2.7. Characteristic nuclear morphology of apoptotic cells  
The nuclear morphology typical for apoptosis was determined 72 h after treatment 
with curcumin by epifluorescence microscopy (Axiovert 35, Opton). The cells were 
trypsinized, centrifuged and washed. Thereafter 10 µl of cell suspension were labeled with 4 
µl of acridine orange (AO, 15 µg/ml in PBS) and 2 µl of ethidium bromide (EtBr, 50 µg/ml in 
PBS) and examined for typical nuclear morphology of apoptotic cells - the condensation of 
chromatin to compact and simple globular geometric figures.  Both live and dead cells take up 
acridine orange. It intercalates into DNA, making it appear green, and binds to RNA, staining 
it red. Thus a viable cell will have bright green chromatin in its nucleus and red-orange 
cytoplasm. Ethidium bromide is only taken up by nonviable cells. It intercalates into DNA, 
making it appear orange, but binds only weakly to RNA, which may appear slightly red. Thus 
a dead cell will have bright orange chromatin (the ethidium overwhelms the acridine) and its 
cytoplasm, if it has any contents remaining, will appear dark red. Cells that have undergone 
necrosis will have the fluorescent features of nonviable cells but will not have apoptotic 
nuclear morphology. Using this method, both normal or apoptotic nuclei in live cells will 
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fluoresce bright green. In striking contrast, apoptotic nuclei in dead cells will fluorescence 
bright orange. Fluorescence was detected through the BP 450-490, FT 510, LP 520 filter. The 
images were taken with the camera Pixera Pro150ES.  
 
2.8. Annexin V-FITC/PI assay  
The appearance of phosphatidylserine (PS) on the extracellular side of membrane, as a 
marker of apoptosis, was evaluated with Annexin V-FITC/PI method as described previously 
(Jakopec et al., 2006). The percentages of three cell death categories were determined: 
apoptotic (AV+, PI-), and secondary necrotic or necrotic (AV+, PI+) and live  cells (AV-, PI). 
Annexin V-FITC was obtained from BD Pharmingen (BD Biosciences, San Jose, CA).  
 
2.9. Western blot  
Cells were seeded and treated with curcumin on the next day. Protein extracts of 
control and treated cells were prepared by lysing 7.5 × 10
5
 cells in 100 µl of 1 × SDS sample 
buffer (0.0625 M Tris HCl, pH 6.8, 2% SDS, 10% glycerol, 0.01% bromphenol blue, 5%(v/v) 
β-mercaptoethanol). Samples were then sonicated, denaturated by boiling in water bath for 1 
min, loaded on 12.5% SDS-polyacrylamide gel, electrophoresed, and transferred to 
nitrocelulose membrane (0.22 µm; Protran, Schleicher & Schuell, DE). Membrane was 
blocked with blocking buffer (TBS containing 0.1% Tween 20 (v/v) (Sigma) and 5% milk 
(w/v) (Sirela, Zagreb, HR) for 1 hour at the room temperature. Primary antibodies (applied for 
1 hour at room temperature or overnight at 4 °C) were: anti-procaspase-3 (sc-7272, Santa 
Cruz) and anti-PARP (556362, Pharmingen). They were diluted 1:1000 (procaspase-3) or 1: 
4000 (PARP). Thereafter, membranes were incubated for 1 h with HRP-labeled sheep anti-
mouse secondary antibody diluted 1:5000 (NA 931V, Amersham Pharmacia Biotech, 
Uppsala, SE) and then developed by an ECL system according to the manufacturer's 
instructions (PerkinElmer, Waltham, MA). 
 
2.10. Determination of fatty acid methyl esters  
HEp-2 and 7T cells were grown in 75 cm
2
 flasks for 48 h until they reached 80% 
confluence. Thereafter, 1.5 × 10
7
 cells were collected by trypsinization, washed with 0.9% 
NaCl and lyzed in 100 µl of dH2O. Total lipids were extracted from lysate with a mixture of 
isopropanol/chlorophorm (1,5:1 v/v) (Rose and Oklander, 1965). Fatty acids were 
transesterified to methyl esters with 2 ml of 1 M HCl in methanol at 100
o
C for 45 min. Fatty 
acid methyl esters were extracted twice with petrol-ether and analyzed by a SRI 8610C GAS 
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CHROMATOGRAPH (SRI Instruments Chromatography Systems, Torrance, CA), equipped 
with a flame ionization detector and a capillary column 007-CW (Quadrex Corporation, 
Woodbridge, USA), length 60 m, i. d. 0.25 mm, and film thickness 0.25 µm. Hydrogen was 
used as a carrier gas with a flow of 60 ml/min in a split mode. The initial oven temperature of 
150
o
C was maintained for 3 min, than increased to 220
o
C at a rate of 8
o
C/min, and the final 
temperature was kept constant for 30 minutes. The injector and detector temperatures were 
250
o
C and 260
o
C, respectively. Fatty acid methyl esters were identified by comparison of 
their retention times to those of known reference standards (Supelco Inc., Bellefonte, PA). 
The results were collected and analyzed using Peak Simple 3D, Version 2.97 (SRI Inc., 
Torrance, CA). 
 
2.11. Statistical analysis 
Data were analyzed by unpaired Student’s t-test and expressed as means ± standard 
deviation. Results of the comet assay parameters are presented as means ± standard error, and 
were evaluated using Statistica 5.0 program package (StaSoft, Tulsa, OK). In order to 
normalize the distribution and equalize the variances of the comet assay data, a logarithmic 
transformation was applied. Multiple comparisons between groups were done by means of 
ANOVA on log-transformed data. Post-hoc analyses of differences were done by the 
Newman-Keuls test. Data were considered statistically significant at p-value of < 0.05. 
 
 
3. Results 
 
3.1. Sensitivity of HEp-2 and 7T cell line to curcumin 
Human laryngeal carcinoma HEp-2 cells and the carboplatin resistant 7T subline were 
exposed to various concentrations of curcumin, and their survival was determined 72 h later.   
Curcumin inhibited the growth of both cell lines in a dose-dependent manner, but carboplatin 
resistant 7T cells were cross resistant to this natural drug (Fig. 1). From obtained survival 
curve we selected two concentrations of curcumin, equimolar and equitoxic, for further 
studies. At equimolar concentration of 25 µM curcumin the differences in cell survival 
between HEp-2 and 7T cells were most pronounced: 30% percent of HEp-2 cells survived this 
curcumin concentration, as compared to 65% of 7T cells. To reach the same survival level, 7T 
cells had to be treated with 40 µM curcumin and this concentration was marked as equitoxic 
concentration.  
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3.2. Curcumin accumulation in HEp-2 and 7T cells        
We quantified curcumin accumulation by flow cytometry since curcumin has the 
ability to fluoresce in the green band. Curcumin fluorescence is weak in aqueous solutions 
(Khopde et al., 2000), but in hydrophobic micelles it is enhanced by nearly 55 times (Wang et 
al., 2006). Since curcumin is a lipophilic compound and accumulates mainly in the 
membranes (Kunwar et al., 2008), its accumulation in hydrophobic parts of membranes 
probably explains significant fluorescence that was detected by flow cytometry. The presence 
of extracellularly bound curcumin is probably not detected due to its weak florescence in 
aqueous solutions. 
Since 50% of curcumin degrades in cell culture medium after 8 h of incubation (Wang 
et al., 1997), we have chosen 1.5 and 3 hour period to measure cellular accumulation of 
curcumin. The results of flow cytometry measurements showed that curcumin accumulation 
in both cell lines is concentration dependent and has the same dynamic. In both cell lines the 
maximum of intracellular curcumin fluorescence was achieved after 1.5 h. However, 7T cell 
line accumulated less curcumin at equimolar curcumin concentration as compared to HEp-2 
line, while at equitoxic concentration the accumulation was similar (Fig. 2A). According to 
the measurements on Beckman Cell Counter (data not shown), and also on flow cytometric 
histograms of cell size distribution represented by Forward Scatter-Height parameter (FSC-
H), we detected smaller average cell size of 7T cells as compared to HEp-2 cells (Fig. 2B). 
Since cell size can influence the amount of accumulated curcumin, it could be possible that 
7T cells accumulate less curcumin due to their smaller average cell size. To see if the 
accumulation of curcumin in 7T cells is also decreased in comparison to HEp-2 cells if only 
the cells of the same size were compared, we created a new approach to analyze flow 
cytometric data. For this purpose we set four gates in FSC-H histogram of both cell lines 
treated with curcumin (R1, R2, R3 and R4) (Fig. 2B) that encompassed cells with increasing 
cell size, and for each cell size the amount of accumulated curcumin was determined. The 
results (Fig. 2C) indicate that in 7T cell line treated with 25 µM curcumin no positive 
correlation for curcumin accumulation and cell size was observed, but for 40 µM curcumin 
this correlation existed, i.e. bigger cells accumulated more curcumin. For HEp-2 cell line this 
correlation was present at both concentrations of curcumin. In 7T cells lower accumulation of 
curcumin was observed at both gates applied (R2 and R3), although this difference was 
statistically significant only for the cells with bigger size (R3 gate). Also, at equitoxic 
concentrations HEp-2 and 7T cells of the same size accumulated the same amount of 
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curcumin (Fig. 2C see R3 gate at 25 µM for HEp-2, and R3 gate at 40 µM for 7T). Therefore, 
7T subline accumulates less curcumin than HEp-2 cell line, and this difference in not caused 
by the different size of the cells in these two populations.  
 
3.3. Curcumin induced ROS formation in HEp-2 and 7T cells   
Numerous literature data suggest that ROS induction is one of the first effects of 
curcumin treatment and it is involved in its cytotoxicity (Chen et al., 2010; Fujisawa S, 2004; 
Khar et al., 2001). Therefore, we examined and compared ROS induction in HEp-2 and 7T 
cells following the treatment with curcumin. Using H2DCFDA probe, ROS induction was 
explored by flow cytometry. Results presented in Fig. 3A show that after only 15 minutes of 
treatment with curcumin the induction of ROS was different in HEp-2 versus 7T cells. The 
level of ROS significantly increased in HEp-2 cells, but only slightly in 7T cells for both, 
equimolar and equitoxic concentrations (Fig. 3A). To further examine the role of ROS 
induction in differential sensitivity of HEp-2 and 7T cells to curcumin, the cells were 
pretreated with NAC or BSO. NAC can directly scavenge free radicals, but it is also involved 
in glutathione (GSH) synthesis. BSO inhibits the synthesis of GSH, and in this way reduces 
the level of antioxidant GSH molecules. After the treatment with equimolar (25 µM) 
concentration of curcumin, the results of MTT assay showed less influence of NAC on 
survival of 7T cells than HEp-2 cells (Fig. 3B). If the cells were pretreated with BSO, again 
the differences in cell survival were more expressed in HEp-2 cells (Fig. 3C). However, the 
influence on cell survival of both, NAC and BSO was similar on HEp-2 and 7T cells when 
equitoxic concentration of curcumin was used (Fig. 3B and 3C) thus indicating that at this 
concentration in both cell lines ROS induction was the same. The possible explanation for the 
discrepancy between MTT data for equitoxic ROS induction (the experiments with NAC and 
BSO) and flow cytometry data (the experiments with direct ROS measurement) could lie in 
the fact that different experimental time points were examined. While ROS induction was 
measured by flow cytometry after only 15 min of treatment with curcumin, because for longer 
incubation time the leakage of H2DCFDA from both cell lines was observed, in MTT 
experiments treatment with curcumin in combination with NAC and BSO lasted much longer. 
Thus, although the survival of both HEp-2 and 7T cells pretreated with NAC or BSO was 
similar for equitoxic doses of curcumin, suggesting that the same amount of ROS was 
induced, at the same dose HEp-2 and 7T cells showed clear difference in the early ROS 
induction.  
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3.4. Curcumin induced lipid and DNA damage in HEp-2 and 7T cells  
ROS can react with most of  cellular macromolecules including lipids and DNA (Kohen 
and Nyska, 2002). Therefore, after we observed that early induction of ROS was different in 
HEp-2 versus 7T cells following the curcumin treatment, we decided to examine and compare 
downstream consequences of ROS formation. Results of HPLC analysis of MDA level, which 
is one of the major final products of lipid peroxidation, showed that curcumin induced lipid 
peroxidation in both cell lines. The level of MDA correlated with cytotoxicity of curcumin: at 
equimolar concentration of curcumin (25 µM), significantly more MDA was determined in 
HEp-2 cells than in 7T cells, but at equitoxic concentration (40 µM) the amount of MDA was 
almost the same (Fig. 4A). 
  Oxidative damage at DNA level was detected by the FPG-modified comet assay. The 
results showed that in both cell lines there was significant increase in DNA strand breaks (Fig. 
4B, see buffer control), but only in HEp-2 cell line a small increase in oxidative DNA damage 
was detected at both concentrations of curcumin used or just for equitoxic dose by the 
parameter of tail moment (Fig. 4B). The presence of DNA strand breaks was also confirmed 
by standard alkaline comet assay (Fig. 4C), which again showed correlation with cytotoxicity 
of curcumin and equitoxic doses showed the similar amount of DNA strand breaks.  
   
3.5. Curcumin induced apoptosis in HEp-2 and 7T cells  
In order to see the downstream effects of curcumin induced ROS formation, lipid and 
DNA damage in HEp-2 and 7T cells, we applied different techniques. The results presented in 
Fig. 5A show typical nuclear apoptotic characteristics (condensation of chromatin to compact 
and simple globular geometric figures)  in HEp-2 and 7T cells after the treatment with 
curcumin.   Further,  phosphatidylserine was exposed on outer side of membrane (Fig. 5B), 
PARP was cleaved and caspase-3 activated (Fig. 5C). All these results indicate that curcumin 
treatment induced apoptotic cell death in HEp-2 and 7T cells. At equimolar concentration of 
curcumin, less apoptotic cells was found in 7T cells (Fig. 5A and 5B); this was confirmed by 
lack of cleavage of PARP and procaspase-3 (Fig. 5C). However, at equitoxic concentration 
apoptosis induction was similar in both cell lines (Fig. 5B and 5C).   
 
3.6. Curcumin induced Hsp70 expression in HEp-2 and 7T cells            
It was found that curcumin induces Hsp70 expression in different cell lines and thereby 
protects them from apoptotic cell death (Khar et al., 2001). Therefore we examined the 
induction of Hsp70 following the treatment with curcumin. As shown in Fig. 5D, at equimolar 
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concentration of curcumin induction of Hsp70 expression was lower in 7T cells, as compared 
to HEp-2 cells, but at equitoxic concentration the induction was similar. Thus it can be 
concluded that Hsp70 expression is proportional to the curcumin induced stress detected in 
both cell lines. 
 
3.7. Fatty acid composition of HEp-2 and 7T cell membranes 
Curcumin is a lipophilic compound and accumulates mainly in the membranes. To 
explain the reduced accumulation of curcumin in 7T cells, we decided to explore membrane 
fatty acid composition. The results of gas chromatography presented in Fig. 6 show that there 
was no difference in fatty acid composition in 7T subline compared to HEp-2 cells. 
 
 
4. Discussion   
 
In order to increase the effectiveness of cancer treatment, the interest has been recently 
focused to the drugs that have been used in traditional medicine  (Chattopadhyay et al., 2004), 
like curcumin. The observed anti-tumor effects of this natural compound encouraged 
extensive efforts to establish its usefulness in cancer prevention and cancer treatment. 
Curcumin could be an excellent candidate to target a multifactorial disease like cancer 
because of its broad range of activities, based on its ability to affect multiple intracellular 
targets (Kunnumakkara et al., 2008; Lopez-Lazaro, 2008; Teiten et al., 2010). 
A particular problem in classic chemotherapy is the drug resistance of tumor cells. The 
drugs that could be efficient against chemoresistant cells could be of great importance in 
enhancing effectiveness of cancer treatment. There are some data in the literature that verified 
anticancer properties of curcumin in drug resistant cells (Labbozzetta et al., 2009; Lu et al., 
2012; Sung et al., 2009; Weir et al., 2007). However, these data should be more abundant in 
order to make more general conclusions about curcumin’s activity against drug resistant cells. 
To our knowledge, such data are missing for laryngeal carcinoma cells. Therefore our study 
was focused on carboplatin resistant human laryngeal carcinoma cells. Our aim was to 
explore their sensitivity to curcumin, and if this sensitivity is altered, to determine the 
molecular mechanism that are responsible for it. We found that carboplatin resistant 7T cells 
are also cross resistant to curcumin. 
Curcumin is a lipophilic compound, unstable in aqueous solutions (Wang et al., 1997), 
In the study on rat thymocytes it was shown that such properties enable this molecule to easily 
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enter the cell and localize in the membrane regions like: plasma membrane, membranes of 
endoplasmic reticulum and nuclear envelope (Jaruga et al., 1998). In one of the recent papers 
it was found that, except for membrane localization, minor nuclear localization occurred in 
mouse spleen lymphocytes, mouse fibroblast (NIH3T3), T cell lymphoma of murine origin 
(EL4) and breast cancer cell line of human origin (MCF7) (Kunwar et al., 2008). Cytotoxicity 
study on these cell lines indicated that curcumin toxicity in one individual cell line increased 
with its increased accumulation, but general correlation between accumulation and toxicity 
was not found. To see if there is some correlation between accumulation and cytotoxicity in 
our model system, curcumin accumulation was explored based on quantifying the 
fluorescence of intracellular curcumin. Our results showed that 7T cells accumulate less 
curcumin compared to HEp-2 cells. Since intracellular curcumin accumulation was similar in 
both cell lines at equitoxic doses, we supposed that reduced cytotoxicity of curcumin applied 
in equimolar doses could be due to lower intracellular accumulation of curcumin in 7T cells. 
To confirm our hypothesis, we explored the downstream events of curcumin accumulation.  
There are numerous reports about the production of reactive oxygen species (ROS) as 
one of the first steps in curcumin cytotoxicity to different tumor cell lines (Atsumi et al., 
2005; Chen et al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et al., 2005). We also detected 
ROS formation quite early after curcumin was added and found more ROS in parental HEp-2 
cells. ROS presence and its role in cytotoxicity were also confirmed for both HEp-2 and 7T 
cell line after longer period of incubation with curcumin combined with NAC and BSO 
treatment. Since both of them influence cellular GSH level, we checked basal GSH 
concentration in both cell lines and found that it was the same (data not shown). Although 
combined treatment of curcumin with NAC or BSO affected the survival of HEp-2 and 7T 
cells, their influence on equitoxic doses of curcumin was similar, suggesting that the same 
amount of ROS was induced after longer incubation time. Due to discrepancies in results 
about ROS amount in 7T cells during short and longer incubation time with equitoxic dose of 
curcumin, we concluded that ROS induction was probably lower in the beginning of the 
treatment (15 min) in the 7T cell line. Contribution to lower early induction of ROS could be 
due to lower accumulation of curcumin detected in 7T cells at the same time (which was 
measured as negative control in ROS experiments) (Fig. S2). But, after longer incubation 
times with equitoxic concentration of curcumin, both cell lines accumulated the same amount 
of curcumin and also impact of ROS on the cytotoxicity was the same. Therefore, we 
concluded that when the same amount of curcumin was accumulated in both cell lines, the 
same amount of ROS was formed. However, early difference in ROS formation and curcumin 
  
15
15
accumulation detected in 7T cells could have some influence on altered response of 7T versus 
HEp-2 cells to curcumin. 
ROS can cause serious damage to lipids, proteins, and DNA (Halliwell and 
Gutteridge, 1999). Since we detected an early alteration in ROS formation following the 
treatment with curcumin, we also measured early ROS induced damage on lipids and DNA. 
Our results showed that curcumin treatment in HEp-2 and 7T cell line induced lipid 
peroxidation and DNA damage after only one hour of treatment. The level of lipid 
peroxidation correlated with cytotoxicity of curcumin. Similar correlation between curcumin 
induced ROS formation, lipid damage and cytotoxicity was observed on primary gingivial 
fibroblast (HGF) and human submandibular adenocarcinoma cells (HSG) (Atsumi et al., 
2005).  
The induction of DNA damage that we observed in HEp-2 and 7T cells following the 
treatment with curcumin is in agreement with those previously reported, despite differences in 
the type of cells and experimental conditions used (Cao et al., 2006; Huang et al., 2011; Jiang 
et al., 2010; Lin et al., 2008; Lopez-Lazaro et al., 2007; Su et al., 2006; Urbina-Cano et al., 
2006). Although we have expected that more oxidative DNA damage (like oxidized purines) 
would appear in HEp-2 and 7T cells because of ROS induction, strand breaks were 
predominant and correlated with cytotoxicity. However, minor oxidative DNA damage was 
found only in HEp-2 cells, and this could be the result of enhanced early ROS induction 
found in these cells. Presence of DNA strand breaks after curcumin treatment could be 
explained by the work of Jiang et al (2010). They showed the role of mismatch repair system 
in curcumin induction of DNA double strand breaks at the place of mutagenic adduct 8-oxo 
guanine. Also, curcumin has been shown to induce topoisomerase I- and II-DNA complexes 
in K562 leukemia cells (Lopez-Lazaro et al., 2007). They were inhibited by the antioxidants 
like NAC, suggesting that their formation was mediated by ROS. Cellular processing converts 
these complexes into permanent DNA strand breaks that trigger cell death (Binaschi et al., 
1995; Champoux, 2001; Onda et al., 2008; Sordet et al., 2003).  
There are numerous reports about ROS involvement in curcumin induced apoptosis in 
the literature (Atsumi et al., 2005; Chen et al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et 
al., 2005). Apoptosis inhibition was found to be one of the causes of  resistance to curcumin 
in some cell lines (Karunagaran et al., 2005). Therefore, we decided to explore curcumin 
induced cell death in HEp-2 and 7T cells. The results of different methods showed that 
curcumin treatment induced apoptotic cell death in both cell lines which was in correlation 
with curcumin cytotoxicity. When intracellular accumulation of curcumin, ROS induction, 
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and the level of lipid and DNA damage were similar in HEp-2 and 7T cells (as observed for 
equitoxic doses of curcumin), the downstream effect, i. e. apoptosis induction, was also 
similar. Therefore, we excluded the alterations in apoptosis induction as possible cause of 
curcumin resistance in 7T cell line. On the contrary, several reports showed that inhibition of 
apoptosis was the cause of curcumin resistance. For example, a number of published data 
reported that overexpression of antiapoptotic proteins, like Bcl-2, Bcl-XL and Smac protected 
cancer cells from curcumin treatment (Karunagaran et al., 2005). Therefore we examined the 
expression of antiapoptotic Bcl-2 protein. We determined its expression until the 24 h after 
the treatment when apoptosis was detected by PARP cleavage (Fig. S3). There were no 
increase in Bcl-2 expression neither in HEp-2 nor 7T cell line during that time period (Fig. 
S2). This further supported our conclusion that altered expression of antiapoptotic proteins is 
not the cause of curcumin resistance in 7T cell line. 
   Hsp70 is usually expressed upon different stress stimuli (Silver and Noble, 2011). 
Curcumin resistant cell lines established from lung, kidney, prostate, cervix, CNS 
malignancies and melanomas showed higher production of antiapoptotic protein Hsp70 upon 
ROS induction and thereby protecting them from apoptotic cell death (Khar et al., 2001). 
Also, human colon cancer cells treated with curcumin were protected from apoptotic cell 
death due to Hsp70 induction upon heat treatment (Rashmi et al., 2003) or ectopic Hsp70 
overexpression (Rashmi et al., 2004). Hsp70 silencing enhanced curcumin induced apoptosis 
in those cancer cells (Rashmi et al., 2004). Therefore, we examined the expression of Hsp70 
in HEp-2 and 7T cells following the treatment with curcumin. At equimolar concentration of 
curcumin the induction of Hsp70 expression was lower in 7T as compared to HEp-2 cells. But 
at equitoxic concentration, the Hsp70 induction was similar in both cell lines. Therefore, we 
can conclude that Hsp70 expression correlates with the level of stress detected in both cell 
lines. However, if Hsp70 induction had some antiapoptotic role during the curcumin 
treatment, its influence was similar in both, curcumin sensitive HEp-2 and resistant 7T cell 
line.  
Changes in drug accumulation can play an important role in drug sensitivity and drug 
resistance of tumor cells (Casas et al., 2011; Fodale et al., 2011; Gottesman, 2002). This can 
be achieved through altered properties in cell membrane lipids as it was recently shown with 
isolated lipids from doxorubicin sensitive (MCF-7) and resistant (MCF-7/ADR) breast cancer 
cells (Peetla et al., 2010). Also, fatty acid analysis of vincristine sensitive KB-3-1 and 
vincristine resistant KB-ChR-8-5 cells showed that the resistant cell line had lower amounts 
of unsaturated fatty acids (Das et al., 1998). In line with that, when membrane phospholipids 
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of L1210 murine leukemia cells were enriched with fatty acids of variable saturation degrees 
the accumulation of adriamycin directly correlated with the degree of fatty acid membrane 
saturation (Burns and North, 1986). 
In order to determine the cause of reduced curcumin accumulation in 7T cells, 
accompanied by its lower cytotoxicity in these cells, we explored some characteristics of cell 
membranes in HEp-2 and 7T cell line, since curcumin is a lipophilic compound and 
accumulates mainly in the membranes. Our results showed that there was no difference in 
membrane fatty acid composition between 7T and HEp-2 cells. We must point out that in our 
experiments we extracted lipids from whole cells, because curcumin can accumulate not only 
in plasma membrane, but also in membranes of endoplasmic reticulum and nuclear envelope 
(Jaruga et al., 1998). Therefore, we can not exclude some differences in fatty acid 
composition between membranes of different cell compartments.  An additional cause of 
changed intracellular curcumin accumulation could be the altered activity of ATP hydrolyzing 
cellular transporters, a superfamily of transmembrane proteins, that export a wide variety of 
natural and synthetic compounds from the cells (Deeley et al., 2006). One of them, the ATP-
binding cassette transporter ABCA1, is involved in cholesterol efflux, but can also influence 
the sensitivity to curcumin, as shown recently (Bachmeier et al., 2009). To further explore the 
molecular mechanisms of altered curcumin accumulation in drug resistant 7T cells, our future 
research will be focused on cell membranes and membrane transporters.  
In conclusion, natural product curcumin derived from plant Curcuma longa has shown 
a wide range of beneficial effects as antitumor agent. Although curcumin exhibits promising 
potential in treatment of chemoresistant cancer cells, we report here for the first time that drug 
resistant cells can become also cross resistant to curcumin, as we found for carboplatin 
resistant laryngeal carcinoma cells.  Reduced curcumin accumulation was one of the possible 
explanations for curcumin resistance. The knowledge about the mechanisms involved in 
modified sensitivity of drug resistant cells to curcumin could be important in the future 
attempts of clinical application of curcumin as antitumor agent, especially in treatment of 
chemoresistant cancers. Our results indicate that the effects of curcumin in the potential 
treatment of drug resistant tumors may depend on tumor type or drug that was involved in 
drug resistance development. Since curcumin is a lipophilic molecule, which leads to 
problems of decreased solubility and bioavailability, intensive research is currently being 
conducted in the field of curcumin delivery. This could be crucial in future attempts of 
overcoming curcumin resistance based on diminished cellular accumulation like the one 
observed in carboplatin resistant 7T cell line.  
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FIGURE CAPTIONS 
 
Figure 1. Survival of human laryngeal carcinoma HEp-2 cells and their derived 
carboplatin resistant 7T subline following the treatment with curcumin. HEp-2 and 7T 
cells were incubated for 72 h with different concentrations of curcumin and their survival was 
determined by MTT assay. The results are shown as mean values of three experiments (± 
S.D.). * p<0.01 and ** p<0.001 versus HEp-2. 
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Figure 2. Impact of incubation time and cell size on the accumulation of curcumin in 
HEp-2 and 7T cells. A) Cells were incubated with 25 and 40 µM curcumin, harvested by 
trypsinization after indicated time intervals, washed twice with PBS, and intracellular 
curcumin fluorescence was analyzed on FACSCalibur flow cytometer. In the presented data 
the autofluorescence of untreated cells (MFI less than 5) was subtracted from the mean 
fluorescence intensity (MFI) of intracellular curcumin in treated cells. The results are shown 
as mean values of three experiments ± S.D. * p<0.05 versus HEp-2. (B) Representative 
histogram of cell size distribution in HEp-2 and 7T cell population after 3 h treatment with the 
indicated concentrations of curcumin. R1, R2, R3 and R4 gates represent cells of different 
size (each gate represents 5-15% of the entire population of analyzed cells). (C) Mean values 
of intracellular curcumin MFI in HEp-2 and 7T cells of different size. The results are shown 
as mean values of three independent experiments (± S.D.). * p<0.05 versus R2 gate of HEp-2; 
** p<0.05 versus R1 gate of  7T; *** p<0.05. 
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Figure 3. Induction of ROS in HEp-2 and 7T cells following the treatment with 
curcumin. A) Cells were pretreated for 30 min with 20 µM H2DCFDA at 37ºC, washed, and 
incubated for 15 min with 25 and 40 µM curcumin. Intracellular DCF (as the measure of 
ROS) and curcumin fluorescence were analyzed on FACSCalibur flow cytometer. FL1 
histograms of HEp-2 and 7T cell population are shown as representative from three 
independent experiments. B) Impact of NAC on cell survival following the treatment with 
curcumin. Cell survival was determined by MTT assay. NAC (10 mM) was added 1 h before 
curcumin and it was present during 72 h treatment with curcumin. Increase in cell survival 
after the treatment with NAC (the number above the connections between two bars) indicates 
the mean value of two experiments. It is calculated by dividing precentage of cell survival 
after curcumin treatment with NAC pretreatment and survival after curcumin treatment alone.  
C) Impact of BSO pretreatment on survival of cells exposed to curcumin, as determined by 
MTT assay. Cells were pretreated with BSO (22.2 µg/ml) for 24 h and then treated with 
curcumin (with BSO) for the next 48 h. Decrease in cell survival (the number above the 
connections between two bars) after the treatment with BSO indicates the mean value of two 
experiments.  It is calculated by dividing precentage of cell survival after curcumin treatment  
alone and survival after curcumin treatment with BSO pretreatment. 
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Figure 4. Induction of lipid and DNA damage during curcumin treatment of HEp-2 and 
7T cells. A) After 1 h treatment with curcumin, cell lysates were analyzed by HPLC and the 
concentration of MDA, as lipid peroxidation product, was determined. The results are shown 
as mean values of two independent experiments . For detection of DNA damage comet assay 
was used and total of 200 randomly captured nuclei were examined from each slide (100 
nuclei from each duplicate slide). Tail length and tail moment were used to measure the level 
of DNA damage. B) FPG comet assay was performed for detection of oxidative DNA damage 
after 1 h treatment with curcumin. * p<0.05 versus buffer. C) Alkaline comet assay was 
performed for detection of DNA strand breaks after 1 h treatment with the indicated 
concentrations of curcumin. * p<0.05. 
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Figure 5. Apoptosis induction and Hsp70 expression in HEp-2 and 7T cells after 
curcumin treatment. A) Apoptotic nuclear morphology of HEp-2 and 7T cells stained with 
acridin orange and ethidium bromide after 72 h treatment with curcumin. Pictures were taken 
at magnification 1000 x. B) Using the the appearance of phosphatidylserine (PS) on the 
extracellular side of membrane, evaluated with AnexinV-FITC/Propidium iodide flow 
cytometry method, the induction of cell death in 10.000 cells was analyzed after 72 h 
treatment with curcumin. The percentages of three cell death categories were determined: 
apoptotic (AnexinV positive (AV+), propidium iodide negative (PI-), and secondary necrotic 
or necrotic (AV+, PI+), as well as and live cells (AV-, PI-). Graph shows representative 
values of two independent experiments. C) Western blot analysis of PARP and procaspase-3 
cleavage as markers of apoptotic cell death. HEp-2 and 7T cells were treated for 72 h with the 
indicated concentrations of curcumin. Membrane stained with Ponceau S was used as loading 
control. Representative of three independent experiments is shown. D) Western blot analysis 
of Hsp70 expression after 24 h treatment with curcumin. Membrane stained with Ponceau S 
was used as loading control. Representative of three independent experiments is shown. 
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Figure 6. Fatty acid composition of the membranes of HEp-2 and 7T cells. HEp-2 and 7T 
cells were cultured for 48 h, washed and thereafter fatty acids were extracted from cell lysates 
and separated by gas chromatography. Proportion of each fatty acid is expressed as a 
percentage of the total fatty acid content determined. The results are shown as mean values of 
four experiments (± S.D.).  
 
Supplement Figure S1. The influence of cell density and medium volume on the survival 
of HEp-2 and 7T cells after the treatment with curcumin.  2.500 HEp-2 cells and 2.500 or 
3.500 7T cells were seeded in 67 µl or 180 µl of medium and next day treated with different 
concentrations of curcumin in final volume of 75 µl or 200 µl, respectively. Both, HEp-2 and 
7T cells were incubated for 72 h with curcumin and their survival was determined by MTT 
assay. Representative of three similar experiments is shown. 
 
Supplement Figure S2. The accumulation of curcumin in HEp-2 and 7T cells after 15 
min treatment. The protocol was the same as described for ROS measurement (paragraph in 
Methods), but without incubation with H2DCFHDA. During that period of time cells were 
kept in the cell medium. Thereafter the cells were incubated for 15 min with 25 and 40 µM 
curcumin, and washed with PBS without Ca
+2
 and Mg
+2
 ions. Intracellular curcumin 
fluorescence was analyzed on FACSCalibur flow cytometer. The results are shown as mean 
values of three experiments ± S.D. * p<0.01 versus HEp-2; ** p<0.05.   
 
Supplement Figure S3. PARP cleavage and Bcl-2 expression during curcumin treatment 
in HEp-2 and 7T cell line. PARP cleavage and Bcl-2 expression were observed during 3, 6, 
12 and 24 h of treatment with equimolar (25 µM) and equitoxic (40 µM) concentrations of 
curcumin by Western blot analysis. Membrane stained with Ponceau S was used as loading 
control. Representative of two independent experiments is shown. 
 
 
